| Derivatives and Hedge Accounting |
Derivatives and Hedge Accounting The Company uses derivative instruments to mitigate cash flow volatility from risk of fluctuations in foreign currency exchange rates and interest rates. The Company enters into foreign currency forward contracts to hedge cash flow risks from forecasted revenues and other transactions denominated in certain foreign currencies. These contracts qualify as cash flow hedges under ASC Topic 815, Derivatives and Hedging, and are with counterparties that are highly rated financial institutions.
The following table sets forth the aggregate notional amount of derivatives in cash flow hedging relationship: | | | | | | | | | | | | | | | | | As of | | | June 30, 2026 | | December 31, 2025 | | Foreign currency forward contracts denominated in: | | | | | | Sell U.S. dollar (USD) | | 992,400 | | | 1,134,800 | | | Buy U.S. dollar (USD) | | 5,159 | | | 12,075 | | | | | | | | | | | | | | | | |
The Company estimates that approximately $28,304 of derivative loss, net, excluding tax effects, included in AOCI, representing changes in the value of cash flow hedges based on exchange rates prevailing as of June 30, 2026, could be reclassified into earnings within the next twelve months. As of June 30, 2026, the maximum outstanding term of the cash flow hedges was approximately 36 months.
The Company also enters into foreign currency forward contracts to hedge its intercompany balances and other monetary assets and liabilities denominated in currencies other than functional currencies, against the risk of fluctuations in foreign currency exchange rates associated with remeasurement of such assets and liabilities to functional currency. These foreign currency forward contracts do not qualify as fair value hedges under ASC Topic 815, Derivatives and Hedging. Changes in the fair value of these financial instruments are recognized in the unaudited consolidated statements of income and are included in the foreign exchange gain, net line item.
The following table sets forth the aggregate notional principal amounts of outstanding foreign currency forward contracts for derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | As of | | Foreign currency forward contracts denominated in: | | June 30, 2026 | | December 31, 2025 | | Sell USD | | 244,088 | | | 217,040 | | | Sell GBP | | 27,880 | | | 35,962 | | | Sell EUR | | 7,376 | | | 7,722 | | | Sell AUD | | 4,619 | | | 4,917 | | | | | | | | Buy USD | | 3,176 | | | 1,837 | | | | | | |
The following table sets forth the fair value of the foreign currency forward contracts and their location on the consolidated balance sheets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives in cash flow hedging relationships | | Derivatives not designated as hedging instruments | | | As of | | As of | | | June 30, 2026 | | December 31, 2025 | | June 30, 2026 | | December 31, 2025 | | Assets: | | | | | | | | | | Other current assets | | $ | 3,419 | | | $ | 4,444 | | | $ | 14 | | | $ | 196 | | | Other assets | | $ | 1,050 | | | $ | 1,424 | | | $ | — | | | $ | — | | | Liabilities: | | | | | | | | | Accrued expenses and other current liabilities | | $ | 31,723 | | | $ | 15,383 | | | $ | 433 | | | $ | 60 | | | Other non-current liabilities | | $ | 16,344 | | | $ | 9,765 | | | $ | — | | | $ | — | |
The following table sets forth the effect of foreign currency forward contracts on AOCI and the unaudited consolidated statements of income:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | Derivative financial instruments: | | 2026 | | 2025 | | 2026 | | 2025 | | Unrealized gain/(loss) recognized in other comprehensive income (“OCI”) | | | | | | | | | | Derivatives in cash flow hedging relationships | | $ | 8,888 | | | $ | 5,955 | | | $ | (37,047) | | | $ | 15,424 | | | | | | | | | | | | Gain/(loss) recognized in unaudited consolidated statements of income | | | | | | | | | | Derivatives not designated as hedging instruments | | $ | 1,747 | | | $ | (1,766) | | | $ | (8,714) | | | $ | (1,286) | |
The following table sets forth the location and amount of gain/(loss) recognized in unaudited consolidated statements of income for derivatives in cash flow hedging relationships and derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | | 2026 | | 2025 | | | As per unaudited consolidated statements of income | | Gain/(loss) on derivative financial instruments | | As per unaudited consolidated statements of income | | Gain/(loss) on derivative financial instruments | | Derivatives in cash flow hedging relationships | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | | | | | | | | | | Revenues, net | | $ | 594,763 | | | $ | 319 | | | $ | 514,460 | | | $ | (1,028) | | | Cost of revenues | | $ | 368,800 | | | (7,043) | | | $ | 320,272 | | | 1,360 | | | General and administrative expenses | | $ | 74,436 | | | (841) | | | $ | 59,549 | | | 126 | | | Selling and marketing expenses | | $ | 49,628 | | | (115) | | | $ | 39,446 | | | 7 | | | Depreciation and amortization expense | | $ | 14,604 | | | (127) | | | $ | 14,055 | | | 89 | | | | | | | | | | | | Total before tax | | | | (7,807) | | | | | 554 | | | Income tax effects on above | | | | 1,575 | | | | | (165) | | | Net of tax | | | | $ | (6,232) | | | | | $ | 389 | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was recognized | | | | | | | | | | | | | | | | | | | Foreign exchange gain, net | | $ | 1,609 | | | $ | 1,747 | | | $ | 2,211 | | | $ | (1,766) | | | | | | | | | | |
The following table sets forth the location and amount of gain/(loss) recognized in unaudited consolidated statements of income for derivatives in cash flow hedging relationships and derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six months ended June 30, | | | 2026 | | 2025 | | | As per unaudited consolidated statements of income | | Gain/(loss) on derivative financial instruments | | As per unaudited consolidated statements of income | | Gain/(loss) on derivative financial instruments | | Derivatives in cash flow hedging relationships | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | | | | | | | | | | Revenues, net | | $ | 1,165,114 | | | 139 | | | $ | 1,015,479 | | | $ | (1,028) | | | Cost of revenues | | $ | 717,070 | | | (11,178) | | | $ | 627,977 | | | (53) | | | General and administrative expenses | | $ | 143,487 | | | (1,368) | | | $ | 118,966 | | | (28) | | | Selling and marketing expenses | | $ | 96,829 | | | (187) | | | $ | 81,371 | | | (9) | | | Depreciation and amortization expense | | $ | 28,607 | | | (135) | | | $ | 27,612 | | | 74 | | | | | | | | | | | | Total before tax | | | | (12,729) | | | | | (1,044) | | | Income tax effects on above | | | | 2,667 | | | | | 217 | | | Net of tax | | | | $ | (10,062) | | | | | $ | (827) | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was recognized | | | | | | | | | | | | | | | | | | | Foreign exchange gain, net | | $ | 2,744 | | | $ | (8,714) | | | $ | 3,403 | | | $ | (1,286) | | | | | | | | | | |
|